-
Jia LIU
Non-equity Partner / Wuhan
-
Tel +86-27-5942-5145
Email liu_jia@zhonglun.com
-
Practices
Private Equity & Investment Funds, Investment/M&A & Corporate Governance, Chinese Mainland Capital Markets
Jia LIU
Ms. Liu has extensive practising experience in Investment/M&A & Corporate Governance, Private Equity & Investment Funds, and Chinese Mainland Capital Markets, focusing on research and legal practice in the biomedical, supply chain trade, and financial industries, and has hosted influential large-scale and complex investment/M&A projects in the relevant industries. Ms. Liu has provided massive annual legal advisory services and specialized legal advisory services for listed companies, state-owned enterprises, and private equity investment institutions.
Representative Matters
Provided legal services for Wuhan Financial Holdings (Group) Co., Ltd. on its acquisition of shares of Jiuzhou Securities Co., Ltd. and obtaining the controlling stake of the company
Provided legal services for HITECK bio (300683) on its investment and acquisition of Xiamen Weijia Pharmaceutical, CVI Medicine, and Zhongmou Medical
Provided legal services for multiple equity investment projects of Wuhan Xincheng Science and Technology Private Equity Fund Management Co., Ltd., Wuhan Optics Valley Growth Venture Capital Fund Co., Ltd., and Changjiang Securities Innovation Investment (Hubei) Co., Ltd.
Provided legal services for the listing projects of companies such as Road Environment (688156), Shengxue Online (871717), Guolitong (835702), Beike Tianyi (870072), Hongshenghua (836281), Kedi Intelligence (872365), Ewatt (834809), and Jingxin Technology (870852) on the National Equities Exchange and Quotations System
Provided annual legal advisory services and specialized legal advisory services for listed companies, state-owned enterprises, and private equity investment institutions such as HITECK bio (300683), Wuhan Yangtze River International Trade Group Co., Ltd. and its subsidiaries, Wuhan Optics Valley Financial Holdings Group Co., Ltd. and its subsidiaries, Wuhan Financial Asset Exchange Co., Ltd.
Memberships & Affiliations
Member of the Medicine and Health Law Professional Committee of Hubei Lawyers Association
Member of Company Professional Committee of Wuhan Lawyers Association
Member of Securities and Capital Professional Committee of Wuhan Lawyers Association
Publications
"Big Data Analysis of A-share Listed Companies Big Health Industry M&A Key legal Issues" (co-author), Wolters Kluwer, 2020
"The Road of Compliance Management of Cosmetics under Strict Supervision" (co-author), Wolters Kluwer, 2021
"From the perspective of Biaotai, the focus of Science and Technology Board on biosimilar drug research and development enterprises and products" (co-author), Wolters Kluwer, 2021
-
Bar Admissions/Professional Qualifications
PRC Bar, 2015
-
Education
LL.M. in International Economic Law, The Chinese University of Hong Kong, 2013-2014
LL.B., Law School, Wuhan University of Technology, 2009-2013 -
Professional Experience
Non-equity partner, and associate, Zhong Lun Law Firm, 2015 to present
-
Languages
Chinese
English